Teva Pharmaceutical Industries | TEVA - Ingresos Por Ventas





Ventas Cambio Fecha
Aspen Pharmacare ZAR 17.08B 4.32B 2025-12
Cipla INR 75.18B 710M 2025-12
Dr.Reddys Laboratories INR 87.27B 780M 2025-12
Guangzhou Baiy CNY 16.05B 7.23B 2026-12
Jiangsu Hengrui CNY 8.14B 300M 2026-03
Kalbe Farma IDR 9.34T 431B 2026-03
Richter Gedeon HUF 214.69B 26.79B 2025-09
Sh Fosun Pharma CNY 10.07B 260M 2026-12
Sun Pharmaceuticals INR 147.99B 3.21B 2025-12
Teva Pharmaceutical Industries USD 11.77B 2.86B 2026-03